FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2625376013> ?p ?o ?g. }

• W2625376013 endingPage "327" @default.
• W2625376013 startingPage "321" @default.
• W2625376013 abstract "Lymphedema can be a debilitating condition, causing a great decrease in a person's quality of life (QoL). Treatment with lymphaticovenular anastomosis (LVA), in which an anastomosis is created between the lymphatic and venous system, may attenuate lymphedema symptoms and reduce swelling. In this study, we share the results using LVA to treat breast cancer-related lymphedema (BCRL) at our institution.Patients were eligible for inclusion if they suffered from unilateral BCRL, if functional lymphatics were available, if compression therapy was used for at least 6 months, and if the follow-up was 12 months at minimum. Lymph vessel functionality was assessed preoperatively using indocyanine green (ICG). During surgery, 1-3 anastomoses were created and shunt patency was confirmed using ICG. Arm volumes were measured before surgery and at 6- and 12-month follow-up. QoL was measured before surgery and at 6-month follow-up. Arm volume differences between the healthy arm and affected arm were compared between the time points.Twenty-nine consecutive female patients with unilateral BCRL were included. The preoperative mean difference in arm volumes was 701 ± 435 ml (36.9%). This was reduced to 496 ± 302 ml (24.7%) at 6-month follow-up (p = 0.00). At 12-month follow-up, the mean difference in arm volume was 467 ± 303 ml (23.5%) (p = 0.02). The overall perceived QoL was increased from 5.8 ± 1.1 to 7.4 ± 0.7 (p = 0.00). The functionality score decreased from 2.2 to 1.8 (p = 0.00), the appearance score decreased from 2.6 to 1.9 (p = 0.00), the symptoms score decreased from 2.8 to 1.8 (p = 0.00), and the mood score decreased from 2.7 to 1.5 (p = 0.00). Fifteen patients (53.6%) were able to discontinue the use of compression garment.Treatment with LVAs is effective in reducing arm volume difference in patients suffering from BCRL. Although no complete reduction of the edema was achieved at 12-month follow-up, the procedure significantly increased the patients' QoL." @default.
• W2625376013 created "2017-06-23" @default.
• W2625376013 creator A5013468858 @default.
• W2625376013 creator A5021833611 @default.
• W2625376013 creator A5038834660 @default.
• W2625376013 creator A5044335787 @default.
• W2625376013 creator A5044721789 @default.
• W2625376013 creator A5053893293 @default.
• W2625376013 creator A5074686825 @default.
• W2625376013 date "2017-06-12" @default.
• W2625376013 modified "2023-09-26" @default.
• W2625376013 title "The efficacy of lymphaticovenular anastomosis in breast cancer-related lymphedema" @default.
• W2625376013 cites W1606553143 @default.
• W2625376013 cites W1965730097 @default.
• W2625376013 cites W1972345859 @default.
• W2625376013 cites W1985271652 @default.
• W2625376013 cites W1991790065 @default.
• W2625376013 cites W2002861424 @default.
• W2625376013 cites W2011590231 @default.
• W2625376013 cites W2014792716 @default.
• W2625376013 cites W2030138377 @default.
• W2625376013 cites W2036872229 @default.
• W2625376013 cites W2043914550 @default.
• W2625376013 cites W2067949232 @default.
• W2625376013 cites W2072804874 @default.
• W2625376013 cites W2077281519 @default.
• W2625376013 cites W2083933440 @default.
• W2625376013 cites W2110421029 @default.
• W2625376013 cites W2110960601 @default.
• W2625376013 cites W2116256977 @default.
• W2625376013 cites W2159162929 @default.
• W2625376013 cites W2194432286 @default.
• W2625376013 cites W2204574960 @default.
• W2625376013 cites W2320116287 @default.
• W2625376013 cites W2320150485 @default.
• W2625376013 cites W2347040651 @default.
• W2625376013 cites W2413354454 @default.
• W2625376013 cites W2511928931 @default.
• W2625376013 cites W2518714340 @default.
• W2625376013 cites W2519073969 @default.
• W2625376013 cites W2555881824 @default.
• W2625376013 cites W2571808603 @default.
• W2625376013 cites W2594240051 @default.
• W2625376013 cites W2600233564 @default.
• W2625376013 cites W2611259468 @default.
• W2625376013 doi "https://doi.org/10.1007/s10549-017-4335-0" @default.
• W2625376013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5543202" @default.
• W2625376013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28608029" @default.
• W2625376013 hasPublicationYear "2017" @default.
• W2625376013 type Work @default.
• W2625376013 sameAs 2625376013 @default.
• W2625376013 citedByCount "45" @default.
• W2625376013 countsByYear W26253760132017 @default.
• W2625376013 countsByYear W26253760132018 @default.
• W2625376013 countsByYear W26253760132019 @default.
• W2625376013 countsByYear W26253760132020 @default.
• W2625376013 countsByYear W26253760132021 @default.
• W2625376013 countsByYear W26253760132022 @default.
• W2625376013 countsByYear W26253760132023 @default.
• W2625376013 crossrefType "journal-article" @default.
• W2625376013 hasAuthorship W2625376013A5013468858 @default.
• W2625376013 hasAuthorship W2625376013A5021833611 @default.
• W2625376013 hasAuthorship W2625376013A5038834660 @default.
• W2625376013 hasAuthorship W2625376013A5044335787 @default.
• W2625376013 hasAuthorship W2625376013A5044721789 @default.
• W2625376013 hasAuthorship W2625376013A5053893293 @default.
• W2625376013 hasAuthorship W2625376013A5074686825 @default.
• W2625376013 hasBestOaLocation W26253760132 @default.
• W2625376013 hasConcept C118552586 @default.
• W2625376013 hasConcept C121608353 @default.
• W2625376013 hasConcept C126322002 @default.
• W2625376013 hasConcept C141071460 @default.
• W2625376013 hasConcept C159110408 @default.
• W2625376013 hasConcept C181152851 @default.
• W2625376013 hasConcept C203014093 @default.
• W2625376013 hasConcept C2777129934 @default.
• W2625376013 hasConcept C2779720271 @default.
• W2625376013 hasConcept C2779951463 @default.
• W2625376013 hasConcept C2781065829 @default.
• W2625376013 hasConcept C2781392513 @default.
• W2625376013 hasConcept C530470458 @default.
• W2625376013 hasConcept C71924100 @default.
• W2625376013 hasConcept C8443397 @default.
• W2625376013 hasConceptScore W2625376013C118552586 @default.
• W2625376013 hasConceptScore W2625376013C121608353 @default.
• W2625376013 hasConceptScore W2625376013C126322002 @default.
• W2625376013 hasConceptScore W2625376013C141071460 @default.
• W2625376013 hasConceptScore W2625376013C159110408 @default.
• W2625376013 hasConceptScore W2625376013C181152851 @default.
• W2625376013 hasConceptScore W2625376013C203014093 @default.
• W2625376013 hasConceptScore W2625376013C2777129934 @default.
• W2625376013 hasConceptScore W2625376013C2779720271 @default.
• W2625376013 hasConceptScore W2625376013C2779951463 @default.
• W2625376013 hasConceptScore W2625376013C2781065829 @default.
• W2625376013 hasConceptScore W2625376013C2781392513 @default.
• W2625376013 hasConceptScore W2625376013C530470458 @default.
• W2625376013 hasConceptScore W2625376013C71924100 @default.
• W2625376013 hasConceptScore W2625376013C8443397 @default.

• next